Neil Chatterji
Stock Analyst at B. Riley Securities
(0.78)
# 2349
Out of 5,370 analysts
26
Total ratings
38.46%
Success rate
9.37%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CLPT ClearPoint Neuro | Maintains: Strong Buy | 20 28 | 11.6 | 141.38% | 4 | Apr 25, 2025 | |
OPRX OptimizeRx | Maintains: Buy | 17 13 | 13.71 | -5.18% | 3 | Dec 24, 2024 | |
AUGX Augmedix | Reinstates: Buy | 6 | n/a | n/a | 3 | Apr 3, 2024 | |
ESTA Establishment Labs H... | Maintains: Buy | 95 50 | 38.93 | 28.44% | 2 | Nov 9, 2023 | |
SILK Silk Road Medical | Downgrades: Neutral | 54 14 | n/a | n/a | 3 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 | 1.23 | 509.76% | 1 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 18 | 12.36 | 45.63% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | 3.25 | 38.46% | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 3 4 | 0.7 | 400% | 3 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 6 | 2.16 | 154.63% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 32 | n/a | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 2.31 | 311.26% | 1 | Oct 4, 2022 |